Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Zfp37 | Rat | 1,2-dichloroethane | decreases expression | ISO | Zfp37 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of ZFP37 mRNA | CTD | PMID:28960355 | Zfp37 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Zfp37 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of ZFP37 mRNA | CTD | PMID:22206623 | Zfp37 | Rat | 1-naphthyl isothiocyanate | decreases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of ZFP37 mRNA | CTD | PMID:25380136|PMID:30723492 | Zfp37 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Zfp37 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ZFP37 mRNA | CTD | PMID:19465110 | Zfp37 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of ZFP37 mRNA | CTD | PMID:22298810 | Zfp37 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Zfp37 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ZFP37 mRNA | CTD | PMID:21570461 | Zfp37 | Rat | 3,4-methylenedioxymethamphetamine | increases expression | EXP | | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ZFP37 mRNA | CTD | PMID:30071829 | Zfp37 | Rat | 3-methylcholanthrene | decreases expression | ISO | Zfp37 (Mus musculus) | 6480464 | Methylcholanthrene results in decreased expression of ZFP37 mRNA | CTD | PMID:35487396 | Zfp37 | Rat | 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in decreased expression of ZFP37 mRNA | CTD | PMID:19162173 | Zfp37 | Rat | 4,4'-diaminodiphenylmethane | decreases expression | EXP | | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of ZFP37 mRNA | CTD | PMID:25380136|PMID:30723492 | Zfp37 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of ZFP37 mRNA | CTD | PMID:30047161 | Zfp37 | Rat | acetaldehyde | increases expression | ISO | ZFP37 (Homo sapiens) | 6480464 | Acetaldehyde results in increased expression of ZFP37 mRNA | CTD | PMID:23416264 | Zfp37 | Rat | aflatoxin B1 | increases expression | ISO | Zfp37 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of ZFP37 mRNA | CTD | PMID:19770486 | Zfp37 | Rat | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of ZFP37 mRNA | CTD | PMID:33354967 | Zfp37 | Rat | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ZFP37 mRNA | CTD | PMID:35163327 | Zfp37 | Rat | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of ZFP37 mRNA | CTD | PMID:30047161 | Zfp37 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of ZFP37 mRNA | CTD | PMID:16483693 | Zfp37 | Rat | arsane | multiple interactions | ISO | ZFP37 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZFP37 more ... | CTD | PMID:39836092 | Zfp37 | Rat | arsenic atom | multiple interactions | ISO | ZFP37 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZFP37 more ... | CTD | PMID:39836092 | Zfp37 | Rat | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of ZFP37 gene | CTD | PMID:28931070|PMID:35440735 | Zfp37 | Rat | benzo[a]pyrene | affects methylation | ISO | ZFP37 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of ZFP37 promoter | CTD | PMID:27901495 | Zfp37 | Rat | benzo[a]pyrene | decreases methylation | ISO | ZFP37 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of ZFP37 exon | CTD | PMID:27901495 | Zfp37 | Rat | beta-lapachone | decreases expression | ISO | ZFP37 (Homo sapiens) | 6480464 | beta-lapachone results in decreased expression of ZFP37 mRNA | CTD | PMID:38218311 | Zfp37 | Rat | beta-lapachone | increases expression | ISO | ZFP37 (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of ZFP37 mRNA | CTD | PMID:38218311 | Zfp37 | Rat | bis(2-chloroethyl) sulfide | increases expression | ISO | Zfp37 (Mus musculus) | 6480464 | Mustard Gas results in increased expression of ZFP37 mRNA | CTD | PMID:15674843|PMID:15674844 | Zfp37 | Rat | bisphenol A | affects methylation | ISO | Zfp37 (Mus musculus) | 6480464 | bisphenol A affects the methylation of ZFP37 promoter | CTD | PMID:27334623 | Zfp37 | Rat | bisphenol A | multiple interactions | ISO | ZFP37 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of ZFP37 gene | CTD | PMID:31601247 | Zfp37 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ZFP37 mRNA | CTD | PMID:25181051|PMID:34947998|PMID:41034487 | Zfp37 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of ZFP37 gene | CTD | PMID:28505145 | Zfp37 | Rat | cadmium dichloride | decreases expression | ISO | Zfp37 (Mus musculus) | 6480464 | Cadmium Chloride results in decreased expression of ZFP37 mRNA | CTD | PMID:24982889 | Zfp37 | Rat | cadmium dichloride | decreases expression | ISO | ZFP37 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of ZFP37 mRNA | CTD | PMID:38568856 | Zfp37 | Rat | chlorpyrifos | increases expression | ISO | Zfp37 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of ZFP37 mRNA | CTD | PMID:37019170 | Zfp37 | Rat | cisplatin | decreases expression | ISO | ZFP37 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of ZFP37 mRNA | CTD | PMID:27392435 | Zfp37 | Rat | cisplatin | multiple interactions | ISO | Zfp37 (Mus musculus) | 6480464 | [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of more ... | CTD | PMID:23625948 | Zfp37 | Rat | copper(II) sulfate | increases expression | ISO | ZFP37 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of ZFP37 mRNA | CTD | PMID:19549813 | Zfp37 | Rat | Dibutyl phosphate | affects expression | ISO | ZFP37 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of ZFP37 mRNA | CTD | PMID:37042841 | Zfp37 | Rat | dichloromethane | increases expression | ISO | Zfp37 (Mus musculus) | 6480464 | Methylene Chloride results in increased expression of ZFP37 mRNA | CTD | PMID:28392392 | Zfp37 | Rat | diethyl maleate | decreases expression | EXP | | 6480464 | diethyl maleate results in decreased expression of ZFP37 mRNA | CTD | PMID:21161181 | Zfp37 | Rat | dioxygen | multiple interactions | ISO | Zfp37 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZFP37 mRNA | CTD | PMID:30529165 | Zfp37 | Rat | dorsomorphin | multiple interactions | ISO | ZFP37 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Zfp37 | Rat | emodin | increases expression | ISO | Zfp37 (Mus musculus) | 6480464 | Emodin results in increased expression of ZFP37 mRNA | CTD | PMID:21319176 | Zfp37 | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of ZFP37 mRNA | CTD | PMID:24793618 | Zfp37 | Rat | folic acid | decreases expression | ISO | Zfp37 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of ZFP37 mRNA | CTD | PMID:25629700 | Zfp37 | Rat | fulvestrant | multiple interactions | ISO | ZFP37 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of ZFP37 gene | CTD | PMID:31601247 | Zfp37 | Rat | furan | decreases expression | EXP | | 6480464 | furan results in decreased expression of ZFP37 mRNA | CTD | PMID:25539665 | Zfp37 | Rat | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of ZFP37 mRNA | CTD | PMID:30047161 | Zfp37 | Rat | Muraglitazar | increases expression | EXP | | 6480464 | muraglitazar results in increased expression of ZFP37 mRNA | CTD | PMID:21515302 | Zfp37 | Rat | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in increased expression of ZFP37 mRNA] | CTD | PMID:20360939 | Zfp37 | Rat | N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of ZFP37 mRNA | CTD | PMID:20360939 | Zfp37 | Rat | N-nitrosodimethylamine | decreases expression | EXP | | 6480464 | Dimethylnitrosamine results in decreased expression of ZFP37 mRNA | CTD | PMID:25380136 | Zfp37 | Rat | paracetamol | increases expression | ISO | ZFP37 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of ZFP37 mRNA | CTD | PMID:26690555 | Zfp37 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of ZFP37 mRNA | CTD | PMID:33387578 | Zfp37 | Rat | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ZFP37 mRNA | CTD | PMID:35163327 | Zfp37 | Rat | perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of ZFP37 mRNA | CTD | PMID:28511854 | Zfp37 | Rat | phenethyl caffeate | multiple interactions | EXP | | 6480464 | caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in increased expression of ZFP37 mRNA] | CTD | PMID:20360939 | Zfp37 | Rat | phenylmercury acetate | decreases expression | ISO | ZFP37 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of ZFP37 mRNA | CTD | PMID:26272509 | Zfp37 | Rat | phenylmercury acetate | multiple interactions | ISO | ZFP37 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Zfp37 | Rat | pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of ZFP37 mRNA | CTD | PMID:19162173 | Zfp37 | Rat | potassium dichromate | increases expression | ISO | Zfp37 (Mus musculus) | 6480464 | Potassium Dichromate results in increased expression of ZFP37 mRNA | CTD | PMID:23608068 | Zfp37 | Rat | propiconazole | decreases expression | EXP | | 6480464 | propiconazole results in decreased expression of ZFP37 mRNA | CTD | PMID:30047161 | Zfp37 | Rat | quercetin | decreases expression | ISO | ZFP37 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of ZFP37 mRNA | CTD | PMID:21632981 | Zfp37 | Rat | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of ZFP37 mRNA | CTD | PMID:28374803 | Zfp37 | Rat | SB 431542 | multiple interactions | ISO | ZFP37 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Zfp37 | Rat | sodium arsenite | increases expression | ISO | ZFP37 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of ZFP37 mRNA | CTD | PMID:38568856 | Zfp37 | Rat | sodium arsenite | decreases expression | ISO | ZFP37 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of ZFP37 mRNA | CTD | PMID:39719251 | Zfp37 | Rat | sodium arsenite | multiple interactions | ISO | ZFP37 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZFP37 more ... | CTD | PMID:39836092 | Zfp37 | Rat | sodium dichromate | decreases expression | EXP | | 6480464 | sodium bichromate results in decreased expression of ZFP37 mRNA | CTD | PMID:25993096 | Zfp37 | Rat | sodium fluoride | decreases expression | ISO | Zfp37 (Mus musculus) | 6480464 | Sodium Fluoride results in decreased expression of ZFP37 mRNA | CTD | PMID:27862939 | Zfp37 | Rat | sulfadimethoxine | decreases expression | EXP | | 6480464 | Sulfadimethoxine results in decreased expression of ZFP37 mRNA | CTD | PMID:30047161 | Zfp37 | Rat | sunitinib | decreases expression | ISO | ZFP37 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of ZFP37 mRNA | CTD | PMID:31533062 | Zfp37 | Rat | Tesaglitazar | increases expression | EXP | | 6480464 | tesaglitazar results in increased expression of ZFP37 mRNA | CTD | PMID:21515302 | Zfp37 | Rat | testosterone enanthate | affects expression | ISO | ZFP37 (Homo sapiens) | 6480464 | testosterone enanthate affects the expression of ZFP37 mRNA | CTD | PMID:17440010 | Zfp37 | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of ZFP37 mRNA | CTD | PMID:30723492 | Zfp37 | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of ZFP37 mRNA | CTD | PMID:23411599 | Zfp37 | Rat | titanium dioxide | decreases methylation | ISO | Zfp37 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of ZFP37 gene | CTD | PMID:35295148 | Zfp37 | Rat | trichloroethene | increases methylation | EXP | | 6480464 | Trichloroethylene results in increased methylation of ZFP37 gene | CTD | PMID:27618143 | Zfp37 | Rat | trichostatin A | multiple interactions | ISO | ZFP37 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Zfp37 | Rat | trichostatin A | decreases expression | ISO | ZFP37 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of ZFP37 mRNA | CTD | PMID:26272509 | Zfp37 | Rat | triphenyl phosphate | affects expression | ISO | ZFP37 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of ZFP37 mRNA | CTD | PMID:37042841 | Zfp37 | Rat | troglitazone | increases expression | EXP | | 6480464 | Troglitazone results in increased expression of ZFP37 mRNA | CTD | PMID:21515302 | Zfp37 | Rat | urethane | increases expression | ISO | ZFP37 (Homo sapiens) | 6480464 | Urethane results in increased expression of ZFP37 mRNA | CTD | PMID:28818685 | Zfp37 | Rat | valproic acid | affects expression | ISO | Zfp37 (Mus musculus) | 6480464 | Valproic Acid affects the expression of ZFP37 mRNA | CTD | PMID:17963808 | Zfp37 | Rat | valproic acid | decreases expression | ISO | ZFP37 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of ZFP37 mRNA | CTD | PMID:23179753|PMID:27188386|PMID:28001369 | Zfp37 | Rat | valproic acid | affects expression | ISO | ZFP37 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of ZFP37 mRNA | CTD | PMID:25979313 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















